When Medications Aren't Enough: Depression Treatment That Works
FDA-cleared rTMS and evidence-based protocols for treatment-resistant depression—delivered with pharmaceutical-grade precision
WHAT IS TREATMENT-RESISTANT DEPRESSION?
THE NEUROBRIDGE APPROACH
Transcranial Magnetic Stimulation (rTMS)
- FDA-cleared since 2008
- 50-60% response rate in treatment-resistant depression
- 30-40% remission rate
- Non-invasive brain stimulation with no systemic side effects
Beyond rTMS: Comprehensive Depression Treatment
- Metabolic optimization
- Anti-inflammatory protocols
- Targeted nutritional support
- IV nutraceutical infusions
WHO BENEFITS
You may be a candidate if:
You have major depressive disorder
You've tried at least 2 antidepressant medications without adequate response
You can commit to 5 sessions per week for 6-8 weeks
No metallic implants in head/neck or history of seizures
WHAT TO EXPECT
Treatment Phase:
6-8 weeks, 5 days per week
Duration:
19 minutes per session
What it feels like:
Tapping sensation on scalp, clicking sound
During treatment:
Awake, alert, can read or listen to music
Assessment:
Depression scales every 5 sessions
Response Patterns:
• Early responders: Notice improvement in 2-3 weeks
• Typical responders: Improvement around week 4-5
• We measure systematically so you know whether it's working
• Typical responders: Improvement around week 4-5
• We measure systematically so you know whether it's working
INSURANCE & INVESTMENT
Most commercial insurance and Medicare cover rTMS for treatment-resistant depression. Prior authorization required—we handle this process.
Ready to try something that works?
If medications haven’t worked, if side effects are intolerable, if you’re tired of being told “try one more,” if you want evidence-based treatment with measurable outcomes—we can help.